Virtu KCG Holdings’s Immune Pharmaceuticals Inc. IMNP Stock Holding History

Virtu KCG Holdings’s Portfolio IMNP Stock Details IMNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-6,484	Closed	-$19K	–	3814
2017 Q1	$19K	Buy	6,484 +3,687	+132%	+$13.3K	﹤0.01%	2982
2016 Q4	$10K	Sell	2,797 -4,755	-63%	-$19.5K	﹤0.01%	3292
2016 Q3	$43K	Buy	7,552 +6,803	+908%	+$50.2K	﹤0.01%	2818
2016 Q2	$6K	Sell	749 -178	-19%	-$1.39K	﹤0.01%	2875
2016 Q1	$8K	Buy	927 +402	+77%	+$4.13K	﹤0.01%	2665
2015 Q4	$8K	Sell	525 -1,631	-76%	-$34.3K	﹤0.01%	3384
2015 Q3	$51K	Buy	+2,156	New	+$67.9K	﹤0.01%	2996
2015 Q2	–	Sell	-2,780	Closed	-$100K	–	3986
2015 Q1	$100K	Buy	+2,780	New	+$104K	﹤0.01%	2652

Other funds holding IMNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Virtu KCG Holdings's IMNP Position: Q2 2017 in Review

Virtu KCG Holdings sold out of Immune Pharmaceuticals Inc. (IMNP) in Q2 2017, closing a stake of 6,484 shares — an estimated $19K sold.

Virtu KCG Holdings first reported a position in IMNP in Q1 2015 and held it in 8 quarters. The position peaked at $100K in Q1 2015. 18 funds tracked by Wall St. Rank hold IMNP as of Q2 2017.

Virtu KCG Holdings reported no remaining Immune Pharmaceuticals Inc. position as of Q2 2017 after selling out during the quarter.
Virtu KCG Holdings sold 6,484 Immune Pharmaceuticals Inc. shares in Q2 2017, an estimated $19K.
Virtu KCG Holdings first reported a position in Immune Pharmaceuticals Inc. in Q1 2015 and held it in 8 quarters.
Virtu KCG Holdings's Immune Pharmaceuticals Inc. position peaked at $100K in Q1 2015.
18 funds tracked by Wall St. Rank held Immune Pharmaceuticals Inc. as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.